Patient Gateway

RSS Feed

Rethinking the clock: Is treatment-free interval truly predictive of platinum sensitivity in small-cell lung cancer?

Gut bacteria shift in lung cancer patients before and after radiotherapy

Gut bacteria shift in lung cancer patients before and after radiotherapy

POEM for paraneoplastic achalasia type II in a patient with anti-Hu antibody-positive small cell lung cancer

Anthony Letai: Phase 3 Trial Shows Major Survival Benefit With Tarlatamab in SCLC

Laura Alder: Honored to Serve as Medical Director of Duke Cancer Institute’s SCLC Center of Excellence

Maintenance Lurbinectedin Raises Stakes of Checkpoint Choice in ES-SCLC

Tarlatamab Combination Extends Small-Cell Lung Cancer Survival

Pumitamig Plus Chemotherapy Shows Antitumor Activity Regardless of Brain Metastasis Status

SEZ6-Targeted Antibody-Drug Conjugate ABBV-706 Demonstrates Promising Antitumor Activity in Relapsed or Refractory Small Cell Lung Cancer